Kailera Therapeutics (KLRA) stock drops as the company posts late-stage trial data for oral GLP-1 candidate HRS-7535 in ...

Iron Mountain earns a Buy rating on growth catalysts and a strong dividend story, with rising cash flow offsetting leverage ...

NVDA’s shift beyond GPUs builds a diversified AI ecosystem, stronger moats, and attractive valuation. Click for this NVDA ...

IPO analysis: debt reduction, strong growth, but seasonal asset-heavy risks. Low EV/EBITDA may mask downside. Read more macro ...

The semiconductor industry remains a critical pillar of technological innovation, powering everything from AI to ...

Palo Alto Networks is rated a Hold after a magnificent 120% surge since April, as cybersecurity stocks went through the roof.

Axon’s Dedrone counter-drone unit is beating expectations as its AI Era Plan revenue surges 700% YoY. Click here to read my ...

Achieve Life Sciences is a more derisked case now, thanks to successful financing, progress on shifting its supply chain and ...

Bioventus stock is upgraded to a "Buy" amid a breakout driven by favorable regulatory developments. Here's what investors ...

My heart wants to Buy. But my head can’t ignore the big valuations following the stocks’ 2026 mega-surge. So for now, I’m at ...

RTX said its Raytheon unit is working with European companies including Diehl Defence to double Stinger missile production in ...

CoreWeave’s revenue surged 112%, and the backlog hit $99.4B as financing improves. Click for more on CRWV stock prospects.